Mehlika Meryem Sarı
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Mehlika Meryem Sarı has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Fatih Ezgu
Division of Pediatric Genetics, Department of Pediatrics Faculty of Medicine, Gazi University Ankara Türkiye
2 shared publications - Filiz Başak Cengiz Ergin
Division of Pediatric Genetics, Department of Pediatrics Faculty of Medicine, Gazi University Ankara Türkiye
2 shared publications - Nilay Kan Menkü
Division of Pediatric Genetics, Department of Pediatrics Faculty of Medicine, Gazi University Ankara Türkiye
2 shared publications - Avniye Kübra Baskın
Department of Pediatric Immunology and Allergy, Gazi University Faculty of Medicine, Ankara, Turkey
1 shared publication Aysel Yüce
Department of Pediatric Gastroenterology and Hepatology Hacettepe University Faculty of Medicine Ankara Turkey
1 shared publicationİlYas Okur
Department of Pediatric Metabolism Gazi University Faculty of Medicine Ankara Turkey
1 shared publication
Latest Publications
- 8 October 2026
- Published by Wiley in Clinical Genetics
A Homozygous ALCAM–CBLB Deletion at 3q13.11‐q13.12 Defines a Candidate Novel Oculo‐Skeletal‐Immune Contiguous Gene Deletion Syndrome
To our knowledge, we report the first combined homozygous deletion of ALCAM and CBLB at 3q13.11‐q13.12. The patient, a 14‐year‐old boy born to consanguineous parents, had a multisystem phenotype with severe congenital ocular and craniofacial anomalies, early‐onset osteoporosis, progressive scoliosis, growth failure, congenital heart defect, humoral immunodeficiency, and chronic inflammatory findings. SNP array identified a 2.5‐Mb homozygous deletion spanning ALCAM and CBLB , and expression studies confirmed complete absence of ALCAM and CBLB expression. Whole‐exome sequencing did not identify an alternative molecular diagnosis. The clinical presentation is likely attributable to combined ALCAM and CBLB loss. Previous animal‐model studies support interpretation of the individual phenotypic components by linking loss of these genes to craniofacial developmental abnormalities, skeletal findings, and immune dysregulation. We propose that this deletion may represent a candidate novel contiguous gene deletion syndrome. This case is the first human phenotype associated with complete ALCAM loss in a contiguous deletion and expands the clinical spectrum associated with disruption of ALCAM and CBLB .
- 8 October 2026
- Published by Wiley in Clinical Genetics
A Homozygous ALCAM–CBLB Deletion at 3q13.11‐q13.12 Defines a Candidate Novel Oculo‐Skeletal‐Immune Contiguous Gene Deletion Syndrome
To our knowledge, we report the first combined homozygous deletion of ALCAM and CBLB at 3q13.11‐q13.12. The patient, a 14‐year‐old boy born to consanguineous parents, had a multisystem phenotype with severe congenital ocular and craniofacial anomalies, early‐onset osteoporosis, progressive scoliosis, growth failure, congenital heart defect, humoral immunodeficiency, and chronic inflammatory findings. SNP array identified a 2.5‐Mb homozygous deletion spanning ALCAM and CBLB , and expression studies confirmed complete absence of ALCAM and CBLB expression. Whole‐exome sequencing did not identify an alternative molecular diagnosis. The clinical presentation is likely attributable to combined ALCAM and CBLB loss. Previous animal‐model studies support interpretation of the individual phenotypic components by linking loss of these genes to craniofacial developmental abnormalities, skeletal findings, and immune dysregulation. We propose that this deletion may represent a candidate novel contiguous gene deletion syndrome. This case is the first human phenotype associated with complete ALCAM loss in a contiguous deletion and expands the clinical spectrum associated with disruption of ALCAM and CBLB .
- 16 September 2026
- Published by Wiley in Pediatric Blood & Cancer
- p. e70700
Hemophagocytic Lymphohistiocytosis in a Patient With Gaucher Disease Having a Homozygous STXBP3 Variant
- 16 September 2026
- Published by Wiley in Pediatric Blood & Cancer
- p. e70700
Hemophagocytic Lymphohistiocytosis in a Patient With Gaucher Disease Having a Homozygous STXBP3 Variant